Literature DB >> 6307918

Replication of herpes simplex virus in human T lymphocytes.

H Teute, R Braun, H Kirchner, H Becker, K Munk.   

Abstract

The replication of herpes simplex virus (HSV) in cultures of human T lymphocytes was investigated. Virus replication occurred only in lymphocyte cultures prestimulated with mitogen. At least one of the factors responsible for this phenomenon is adsorption of the virus to the cells, which was 5 times less efficient in nonstimulated cells than in stimulated cultures. Growth of virus in infected cultures was restricted to lymphocytes of T origin. This was shown by successful infection of highly purified T-cell cultures and by virus replication in four continuous T-cell lines. No virus production was obtained in cultures of lymphocytes of other than T-cell origin. Virus titers in T-lymphocyte cultures reached 10(7) PFU/ml, which was a four log10 step increase over the input dose. Lymphocytes infected with a syn strain of HSV, HSV-ANG, induced polykaryocyte formation in the cultures and therefore generated a CPE visible by microscopic examination. Infection with syn+ strains of HSV (i.e., strains which do not cause cell fusion) did not lead to such phenomena. Not more than 1% of infected T cells was replicating HSV, as revealed by infectious center assays. In contrast, about 5% of these cells showed positive immunofluorescence with anti-HSV antibodies, indicating the presence of cells which express viral protein but do not actively produce infectious virus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307918     DOI: 10.1159/000149371

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  11 in total

1.  Non-productive infection of human newborn blood mononuclear cells with herpes simplex virus: effect on T cell activation, IL-2 production and proliferation.

Authors:  A Hayward; M Laszlo; M Turman; A Vafai; D Tedder
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

2.  The role of epithelial cell differentiation in the expression of herpes simplex virus type 1 in normal human oral mucosa in culture.

Authors:  Y Yura; H Iga; K Terashima; H Yoshida; T Yanagawa; Y Hayashi; M Sato
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1.

Authors:  Z Mikloska; L Bosnjak; A L Cunningham
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  HSV infected RAJI-cells specify HSV specific immediate early and/or early DNA-binding proteins.

Authors:  M Lehtinen
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus.

Authors:  C M Posavad; J J Newton; K L Rosenthal
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Inhibition of herpes simplex virus type 1 replication in fibroblast cultures by human blood mononuclear cells.

Authors:  P J Leibson; M Hunter-Laszlo; A R Hayward
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

7.  A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages.

Authors:  Kevin R Mott; David Underhill; Steven L Wechsler; Terrence Town; Homayon Ghiasi
Journal:  Virol J       Date:  2009-05-13       Impact factor: 4.099

8.  Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice.

Authors:  Kevin R Mott; Homayon Ghiasi
Journal:  Clin Vaccine Immunol       Date:  2008-10-29

9.  Lymphoid-related CD11c+ CD8alpha+ dendritic cells are involved in enhancing herpes simplex virus type 1 latency.

Authors:  Kevin R Mott; David Underhill; Steven L Wechsler; Homayon Ghiasi
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

10.  Inclusion of CD80 in HSV targets the recombinant virus to PD-L1 on DCs and allows productive infection and robust immune responses.

Authors:  Kevin R Mott; Sariah J Allen; Mandana Zandian; Omid Akbari; Pedram Hamrah; Hadi Maazi; Steven L Wechsler; Arlene H Sharpe; Gordon J Freeman; Homayon Ghiasi
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.